dr hab. Agnieszka Pałucha-Poniewiera

dr hab. Agnieszka Pałucha-Poniewiera

+48 12 6623288
pokój 313
Zakład Neurobiologii

Dokonania naukowe

  • Publikacje

The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice

Autorzy: Podkowa, K., Pilc, A., Podkowa, A., Sałat, K., Marciniak, M., Pałucha-Poniewiera, A.

DOI: 10.1016/j.neuropharm.2018.08.022
Date: 2018-01-01

The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug

Autorzy: Pałucha-Poniewiera, A.

DOI: 10.1016/j.pharep.2018.02.011
Date: 2018-01-01

The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test

Autorzy: Pałucha-Poniewiera, A., Podkowa, K., Lenda, T., Pilc, A.

DOI: 10.1016/j.pnpbp.2017.06.022
Date: 2017-01-01

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats

Autorzy: Podkowa, K., Pochwat, B., Brański, P., Pilc, A., Pałucha-Poniewiera, A.

DOI: 10.1007/s00213-016-4325-7
Date: 2016-01-01

Glutamate-Based Drug Discovery for Novel Antidepressants

Autorzy: Pałucha-Poniewiera, A., Pilc, A.

DOI: 10.1080/17460441.2016.1213234
Date: 2016-01-01

Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495

Autorzy: Podkowa, K., Podkowa, A., Sałat, K., Lenda, T., Pilc, A., Pałucha-Poniewiera, A.

DOI: 10.1016/j.neuropharm.2016.08.031
Date: 2016-01-01

A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action

Autorzy: Podkowa, K., Rzeźniczek, S., Marciniak, M., Acher, F., Pilc, A., Pałucha-Poniewiera, A.

DOI: 10.1016/j.neuropharm.2015.05.039
Date: 2015-01-01

Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc

Autorzy: Szewczyk, B., Pochwat, B., Rafało, A., Palucha-Poniewiera, A., Domin, H., Nowak, G.

DOI: 10.1016/j.neuropharm.2015.08.026
Date: 2015-01-01

Erratum: NMDA antagonists under investigation for the treatment of major depressive disorder (Expert Opinion on Investigational Drugs (2014) 23:9 (1181-1192))

Autorzy: Pochwat, B., Palucha-Poniewiera, A., Szewczyk, B., Pilc, A., Nowak, G.

DOI: 10.1517/13543784.2014.961789
Date: 2014-01-01

NMDA antagonists under investigation for the treatment of major depressive disorder

Autorzy: Pochwat, B., Pałucha-Poniewiera, A., Szewczyk, B., Pilc, A., Nowak, G.

DOI: 10.1517/13543784.2014.918951
Date: 2014-01-01

Zobacz także